Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 12/20 | 0.40 |
| ▸ | RXRB | P28702 | 11/20 | 0.40 |
| ▸ | RXRG | P48443 | 10/20 | 0.40 |
| ▸ | CYP26B1 | Q9NR63 | 2/20 | 0.31 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23439337 | 0.93 | RXRA (0.36) | RXRARXRBRXRG | |
| SCHEMBL23438799 | 0.92 | RXRA (0.41) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL22949171 | 0.92 | RXRA (0.43) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL22934127 | 0.89 | RXRA (0.39) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL23439530 | 0.85 | RXRA (0.34) | RXRARXRBRXRG | |
| SCHEMBL22948634 | 0.84 | RXRA (0.36) | RXRARXRBRXRG | |
| SCHEMBL23438786 | 0.84 | RXRA (0.40) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL23439432 | 0.83 | AHR (0.34) | RXRARXRBRXRG | |
| SCHEMBL23439467 | 0.83 | RXRA (0.32) | RXRARXRBRXRG | |
| SCHEMBL23439019 | 0.83 | RXRA (0.40) | RXRARXRBRXRGCYP26B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| WO-2021107681-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11780856-B2 | Compound and organic light-emitting device comprising same | CRY1, CRY2, LEF1 | RXRA 2187/4885RXRB 2732/4885RXRG 2562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.